A clinical trial update was posted on November 4, 2026, for a study involving mibavademab. The trial, registered as NCT07235917, is titled "A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea." It is listed as a Phase 2 study. According to the registry, the trial status is currently recruiting. No results have been posted for this study at this time. The listing does not provide outcome data, efficacy claims, or safety findings. This update reflects only the trial's current recruitment status and design phase as recorded in the public registry. Readers interested in gonadorelin, which is relevant to reproductive hormone research and is an approved compound, can review a general compound overview for additional background and context.
Phase 2 Trial on Mibavademab in Amenorrhea Now Recruiting
See the full gonadorelin overview
Source: https://clinicaltrials.gov/study/NCT07235917